BPC-157 stacking.

BPC-157 with TB-500

The complete Wolverine guide covers the combined peptide, dedicated dosage and results articles, and the 20 mg blend vial and prefilled pen.

Wolverine is the name used for BPC-157 combined with TB-500. People use the name for a premixed blend or for the two ingredients taken separately. A public four-week account, for example, describes a single blend containing equal amounts of both. [1]

The name tells you the ingredient pairing. It does not tell you the amount per ingredient, the concentration, the schedule or the exact formulation. Those details have to come from the label and product documentation.

For example, 10 mg BPC-157 plus 10 mg TB-500 is a 20 mg blend. A 20 mg plus 20 mg version contains 40 mg combined. Both are 1:1, but the second contains twice as much material. These are label-reading examples, not additional products in the four-product BPC-157 comparison.

“10 mg blend” and “10 mg + 10 mg” are different totals. A 1:1 vial containing 10 mg combined holds 5 mg BPC-157 and 5 mg TB-500. A vial containing 10 mg of each holds 20 mg combined. The calculator needs the combined amount from the full ingredient list, not a shortened product name.

BPC-157 vs TB-500

The two ingredients have different sequences. Equal milligrams describe the product’s 1:1 ratio; they do not establish equal biological effects or a replacement dose. The supplied blend certificate identifies BPC-157 at 1419.8 Da and the full-length thymosin beta-4 at 4963.7 Da. [6]

TB-500 naming is inconsistent across products. An original laboratory analysis identified a seven-amino-acid thymosin beta-4 fragment, Ac-LKKTETQ, in a product sold as TB-500. That shorter fragment is different from the 43-amino-acid ingredient in this Wolverine vial. Check the sequence and identity result when comparing products; a study of one form does not automatically describe the other. [5] [6]

Does “500 mcg Wolverine” mean 500 mcg of each?

Only if the instructions explicitly say “500 mcg of each.” In a 1:1 blend, 500 mcg combined contains 250 mcg BPC-157 and 250 mcg TB-500. The difference is a factor of two.

Arithmetic examples. The table is not a set of suggested doses.

A ratio other than 1:1 needs a different calculation. Divide the amount of one ingredient by the total ingredient amount to find its share. For example, a label listing 10 mg BPC-157 and 5 mg TB-500 is 2:1: two-thirds BPC-157 and one-third TB-500.

In that 2:1 example, a 1,500 mcg combined portion contains 1,000 mcg BPC-157 and 500 mcg TB-500. Dividing the total in half only works for a 1:1 blend.

Write the ingredients separately when recording use: “BPC-157: X; TB-500: Y.” That is clearer than a single number followed by “Wolverine,” especially when comparing someone else's report with a different blend.

What amounts and cycle lengths do people report?

One original account by u/604Hustle describes 500 mcg BPC-157 plus 500 mcg TB-500 daily for four weeks. The writer reported marked improvement in a shoulder problem by the end of the course and comfortable pressing months later. The shoulder diagnosis was not confirmed. [1]

Another writer, u/Main-Pea-912, used BPC-157 at 250 mcg twice daily and TB-500 at 1,500 mcg three times weekly for six weeks, and reported no improvement in the targeted musculoskeletal symptoms. [2]

These are actual reported schedules, including an outcome that was disappointing. They are not a trial comparing frequencies, and they do not show that extending a course, increasing an amount or switching to a blend would fix a nonresponse. Individual dosing and injection instructions need a qualified clinician familiar with the specific formulation.

Notice that a daily 1:1 blend and two separately scheduled ingredients are different routines. Their weekly totals can differ even if both are described online as “the Wolverine stack.”

How much material does a reported routine use?

The four-week example above totals 1 mg combined per day. Multiplying that amount by days gives 7 mg combined per week and 28 mg over 28 days. Each ingredient accounts for half.

Calculated quantities, not recommendations to use a four-, six- or eight-week course. Only the first-person account above supplies the four-week example.

A hypothetical 20 mg combined vial contains 20 nominal 1 mg portions; a 40 mg combined vial contains 40. Actual usable amounts may be lower because of preparation and delivery losses. Package quantity also says nothing about how long a prepared solution remains suitable to use.

Adding liquid changes concentration, not the total milligrams in the vial. A volume marking only becomes meaningful when the concentration of each ingredient is known. The dosage guide explains the distinction between milligrams, micrograms and volume; never transfer a BPC-only measurement to a blend without recalculating its ingredients.

Is the concentration for the blend or for each ingredient?

That wording matters too. A 1:1 product labelled 10 mg/mL combined contains 5 mg/mL BPC-157 and 5 mg/mL TB-500. A product labelled 10 mg/mL of each contains 20 mg/mL combined. The second is twice as concentrated overall, even though the same number appears prominently on both descriptions.

Keep three quantities separate when reading a label: total milligrams in the container, milligrams per millilitre, and milligrams of each ingredient. Container volume belongs beside them. If one is missing or ambiguous, a syringe marking or a pen click cannot fill the gap. Request the complete concentration statement before treating someone else's measurement as comparable.

20 mg Wolverine calculator: total blend, each ingredient, mL and U-100 units →

Premixed blend or separate products: what changes?

A blend can simplify the ingredient ratio on paper, but it does not make the ingredients individually adjustable. Doubling the delivered amount doubles both components. That matters if an online instruction says to change only BPC-157.

“Separate products” also does not mean that two liquids can automatically be mixed into the same syringe or vial. Compatibility, stability and sterility are separate product questions. A forum combination name does not answer them.

Does adding TB-500 give better results?

People combine the ingredients hoping for better injury recovery, less pain and improved movement. Whether the second ingredient adds a useful benefit is a separate question from whether the combination is well known.

In the small human knee report, three of four patients receiving BPC-157 plus thymosin beta-4 reported improvement, compared with 11 of 12 receiving BPC alone. These tiny, nonrandomized groups cannot establish that one approach is better. The clinical report also named thymosin beta-4; a commercial TB-500 label needs its own identity information. [3]

A 2026 study directly compared BPC-157, TB-500, their combination and a control in 32 rats after Achilles-tendon repair. Some tissue-healing measures improved, and TB-500 had a significant mechanical-strength advantage at four weeks. The combination did not add benefit over either ingredient alone in that experiment. [4]

That result does not settle every human use. It does mean the claim “two ingredients must work better together” should not be treated as an established fact. The benefits article explains the tissue-repair findings, while the results article shows the reported changes in people's symptoms and function.

Avoid counting the same BPC-157 twice

Wolverine already contains BPC-157. A separate BPC product adds more BPC; it does not replace the BPC portion of the blend unless that is explicitly accounted for.

For a purely arithmetic example, 1 mg of a 1:1 blend contains 500 mcg BPC-157. Another 500 mcg BPC-only amount makes the labelled BPC total 1,000 mcg. The TB-500 total stays at 500 mcg. That combination is no longer 1:1 overall.

If the extra product uses a different route—such as a capsule alongside an injection—you can add the labelled ingredient amounts for your record, but you cannot assume the same amount reaches the body from both. There is no reliable oral-to-injection conversion for these featured products.

The same label check applies to other named blends. If a GLOW or KLOW label includes BPC-157 or TB-500, include those amounts in the ingredient list. Names should never substitute for reading the actual formula.

Are the four featured BPC-157 products Wolverine blends?

No. The four products compared here list BPC-157 without TB-500. Their quantities are below. The spray figures follow the reference specification; confirm the current bottle label.

The product comparison compares the formats and batch-report details. The prefilled pen details explains why total milligrams and concentration do not establish the amount per click.

A purity result from a BPC-only vial or capsule also does not certify a separate blend. For a combination, match the batch report to the actual product and look for the identity and amount of both labelled ingredients. A large purity percentage alone cannot supply a missing ingredient ratio.

How to make a stack description useful

A useful description fits on a short record: both ingredient names, each amount, each frequency, the route, start and stop dates, and the specific outcome being followed. Add the brand and batch so a future product change is visible.

If several ingredients change together, the record cannot easily identify which caused either improvement or an unwanted effect. Keep that uncertainty attached to the account. The side-effects guide covers symptoms people report and the signs that need prompt attention.

Compare BPC-only and combination results, including pain changes, movement and recovery timelines.